Federal Judge Alters Course in High-Profile Murder Case
In a significant turn of events, a federal judge has reduced the severity of charges against Luigi Mangione, altering the trajectory of a case that has captivated national attention. Mangione, accused of the high-profile killing of UnitedHealthcare CEO Brian Thompson, will no longer face the death penalty after two charges were dropped.
Luigi Mangione speaking with his attorney Karen Agnifilo in Manhattan Criminal Court on December 12, 2025 in New York City. Curtis Means/Pool/Getty Images
The dropped charges, which included murder through the use of a firearm and a firearms offense, initially made Mangione eligible for capital punishment. However, two charges of interstate stalking remain. If convicted on these charges, Mangione could face life imprisonment without parole.
Federal prosecutors described the murder as a “premeditated, cold-blooded assassination that shocked America.” The decision to drop the charges now leaves them with a 30-day window to appeal.
Mangione’s defense attorney, Karen Agnifilo, expressed relief and called the judge’s decision an “incredible decision” outside the courthouse. She noted, “We’re prepared and have been prepared to fight this case, and we look forward to fighting this case.”
The case against Mangione does not end with the federal charges. He will also be tried in New York State on charges including murder and possession of a forged instrument, with the top charge carrying up to 25 years to life in prison.
Judge Margaret Garnett, in her written opinion, acknowledged the complex nature of Supreme Court precedents, noting that the analysis may appear “tortured and strange,” but emphasized her fidelity to the law.
In a separate ruling, Judge Garnett decided that evidence found in Mangione’s backpack, including a handgun and a red notebook, will be admissible in the federal trial. Despite the defense’s argument against its admissibility due to the lack of a search warrant, the judge stated, “Such a search was reasonable under the facts of this case.”
With jury selection for the federal trial set for September, both sides anticipate an extensive process due to the case’s notoriety. A comprehensive pre-screening of potential jurors will be conducted, allowing attorneys time to evaluate the candidates thoroughly.
This article was originally written by www.npr.org



